Delivery Order SPE2DB22D3301-SPE2DB25FZ0HC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,903.44 for IMFINZI (120 mg/2.4 mL vials), an oncology pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp represents a $1,903.44 firm fixed-price contract for IMFINZI 120 mg/2.4 ml vials to be delivered by August 21, 2025. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm, with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for Imfinzi 500 mg/10 mL vials on July 31, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMFINZI 500 MG/10 ML vials valued at $26,525.70 with a firm fixed price structure. This contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $15,166.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for IMFINZI 500 mg/10 mL vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- This is a $7,710 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of IMFINZI 500 MG/10 ML vials, a pharmaceutical product. The order has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,535,133 units of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has a completion date of February 26, 2024 and a potential value of $15,420.00. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 500 mg/10 ml vials of the drug IMFINZI, with a potential value of $15,058.32 and a completion date of January 22, 2024. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and medical supplies to support DLA programs. This delivery order does...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0HCDelivery Order
The Defense Logistics Agency awarded a $18,567.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of IMFINZI 500 mg/10 ml vials. The contract is a non-set-aside competitive award with a completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for IMFINZI, a specialty oncology pharmaceutical, represents a routine procurement action under this established prime vendor contract supporting Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/2/25 |